FDA initiative for diversity in cancer studies disappears : Shots
Key guidance to industry on enhancing diversity in clinical trials of cancer drugs disappeared from the Food and Drug Administration...
FDA
FDA Clears Cresilon’s Gel For Severe Blood Loss
Topline Traumagel—the first gel-based therapy to prevent life-threatening bleeding—was cleared for market use Thursday, and its manufacturer said its fast-acting...
Colon cancer blood screening test approved by FDA: ‘Early detection is critical’
Screening for the second leading cause of cancer deaths just got a bit easier.The U.S. Food and Drug Administration (FDA)...
